Mercury Laboratories Limited

₹750.00As of Sun 8 Nov 2026, 12:00 UTC
BSE:538964Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 4.10%
Div yield 0.47%
ROE 5.58%
Pharmaceutical Preparations
Beta (5Y) 0.34
PE TTM 28.18
TSR TTM (12.82%)
Mkt cap ₹900.0M
ROIC 4.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹847
12.87%
(73.00%)
Hold 6|0|6|0|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
8.37
8.90
8.96
9.53
1.68%
6.74%
11.32%
20.59%
Revenue₹M
69.54
68.06
69.29
68.40
13.05%
6.07%
6.30%
(0.01%)
Peers (US$9.584M)
Cap (US$)
PE
9.372M
9.744x
9.983M
41.38x
Capital
TTM
5Y
10Y
Leveragex
0.778
(0.252)
(0.233)
EBIT/Intx
2.002
0.076
0.074
Own earn%
(83.75)
(25.99)
(30.92)
Sh yield%
9.89
32.35
33.85
Owners
Insiders/Inst%
1.20
68.11
Short interest%
3.66
SBC / revenue%
0.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
6–12
$1 testx
0.0
Incr. ROIC%
10